Effect: slow down the progression of lung fibrosis

Conditions:

• IPF - Idiopathic Pulmonary Fibrosis
• Can be used in any progressive fibrotic conditions ILD - Interstitial Lung Disease

CI:

• Thromboembolic disease
• Lung toxicity
• Gastric perforation
• Smoking
• Kidney failure
• Liver failure

MOA: TKi against GF receptors

• VEGF (vascular endothelial)
• FGF (fibroblast)
• PDGF (platelet-derived)

Admin: 150mg po BID

Pro: More accessible

• Reducing flaire up, preventing people from getting worse